Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)

• Marina V. Mayevskaya,
• Ye. N. Bessonova,
• P. O. Bogomolov,
• N. I. Geyvandova,
• K. V. Zhdanov,
• V. G. Morozov,
• V. D. Pasechnikov,
• I. Yu. Khomenko,
• A. V. Yagoda,
• V. T. Ivashkin

Affiliations

Marina V. Mayevskaya

Federal state educational government-financed institution of higher education «Sechenov First Moscow state medical university»

Ye. N. Bessonova

State healthcare institution «Sverdlovsk regional hospital No. 1»

P. O. Bogomolov

Tsentrosoyuz LLC Hospital

N. I. Geyvandova

State government-financed healthcare institution «Stavropol regional clinical center of specialized medical care»

K. V. Zhdanov

Federal state educational government-financed institution of higher professional education Kirov military medical academy

V. G. Morozov

LLC Medical company «Gepatolog»

V. D. Pasechnikov

State educational government-financed institution of higher professional education «Stavropol state medical university» of Ministry of healthcare of the Russian Federation, Stavropol, the Russian Federation

I. Yu. Khomenko

Municipal budgetary healthcare institution «Semashko Municipal hospital No. 1»

A. V. Yagoda

State government-financed healthcare institution of Stavropol region «Stavropol regional clinical center of specialized medical care»

V. T. Ivashkin

Federal state educational government-financed institution of higher education «Sechenov First Moscow state medical university»